Literature DB >> 19280589

Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer.

Daniele Marrelli1, Corrado Pedrazzani, Anna Berardi, Giovanni Corso, Alessandro Neri, Lorenzo Garosi, Carla Vindigni, Annalisa Santucci, Natale Figura, Franco Roviello.   

Abstract

BACKGROUND: Recent studies have suggested that Helicobacter pylori (H. pylori) infection may be related to better prognosis in patients with gastric cancer, but to the authors' knowledge, this finding has not yet been validated. In the current study, the association between H. pylori status and clinical outcome was investigated in a large cohort of patients.
METHODS: Frozen non-neoplastic gastric mucosa and serum samples obtained from 297 patients who underwent surgery for primary gastric cancer between 1988 and 2004 were retrieved from the serum and tissue bank of the study department. H. pylori status was defined by means of polymerase chain reaction (PCR) analysis for the vacA gene in gastric mucosa and by serologic assay of H. pylori and CagA antibodies. Univariate and multivariate analyses were used for the association between clinicopathologic variables and long-term outcome.
RESULTS: Positivity for H. pylori infection was observed in 256 of 297 patients (86%), whereas in 41 patients (14%), PCR for vacA and both serologic tests were negative. Negative H. pylori status was found to be significantly associated with cardia location, advanced pT classification, noncurative surgery, and a lower 5-year survival rate after R0 resection (24% vs 57%; P < .001). Multivariate survival analysis confirmed H. pylori status as a significant prognostic factor (hazards ratio, 2.47; 95% confidence interval, 1.40-4.35 [P = .002]). The influence of H. pylori status on long-term survival was observed in patients with early as well as advanced pT classifications.
CONCLUSIONS: Negative H. pylori status appears to be an indicator of poor prognosis in patients with gastric cancer, and is independent of other well-known clinical and pathologic prognostic variables.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280589     DOI: 10.1002/cncr.24253

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  36 in total

1.  Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.

Authors:  Jennifer M Kolb; Umut Ozbek; Noam Harpaz; Randall F Holcombe; Celina Ang
Journal:  J Gastrointest Oncol       Date:  2017-06

2.  Relationship between serum inflammatory cytokines and lifestyle factors in gastric cancer.

Authors:  Xian Sun; Chun-Jie Xiang; Juan Wu; Wei Dong; Zhen Zhan; Rui-Ping Wang; Jun-Feng Zhang
Journal:  Mol Clin Oncol       Date:  2019-01-22

Review 3.  Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.

Authors:  Yun Shao; Kun Sun; Wei Xu; Xiao-Lin Li; Hong Shen; Wei-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Inflammation-related factors predicting prognosis of gastric cancer.

Authors:  Wen-Jun Chang; Yan Du; Xin Zhao; Li-Ye Ma; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1).

Authors:  Giovanni Corso; Daniele Marrelli; Corrado Pedrazzani; José Carlos Machado; Stefano Mancini; Raquel Seruca; Franco Roviello
Journal:  J Gastrointest Surg       Date:  2009-08-07       Impact factor: 3.452

6.  Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer.

Authors:  F Wang; G P Sun; Y F Zou; F Zhong; T Ma; X Q Li; D Wu
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

7.  Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population.

Authors:  Theresa H Nguyen; Niharika Mallepally; Tariq Hammad; Yan Liu; Aaron P Thrift; Hashem B El-Serag; Mimi C Tan
Journal:  Dig Dis Sci       Date:  2019-11-14       Impact factor: 3.199

8.  Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without Helicobacter pylori Infection.

Authors:  Wen-Liang Fang; Kuo-Hung Huang; Shih-Ching Chang; Chien-Hsing Lin; Ming-Huang Chen; Yee Chao; Su-Shun Lo; Anna Fen-Yau Li; Chew-Wun Wu; Yi-Ming Shyr
Journal:  Oncologist       Date:  2019-02-22

9.  Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer.

Authors:  Hai-Bo Qiu; Li-Yi Zhang; Rajiv-Prasad Keshari; Guo-Qiang Wang; Zhi-Wei Zhou; Da-Zhi Xu; Wei Wang; You-Qin Zhan; Wei Li
Journal:  BMC Cancer       Date:  2010-07-17       Impact factor: 4.430

Review 10.  Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer.

Authors:  Hui-Ying Ma; Xin-Zhou Liu; Chun-Min Liang
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.